Peripheral Intravenous Catheters Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Peripheral intravenous catheters, commonly known as IV cannulas or catheters, are thin, flexible tubes inserted into peripheral veins to administer fluids, medications, blood products, and nutritional support. The market has expanded rapidly over the past five decades, with adoption accelerating significantly in the aftermath of the COVID-19 pandemic as healthcare systems confronted higher demand for intravenous therapies and hospital admissions.

• •Estimated global market value of $4.20 billion in 2025, forecast to reach $5.47 billion by 2030 at a 5.45% CAGR
• •Over one billion PIVCs inserted annually worldwide, with more than 170 million units deployed each year in the United States
• •Represents a multibillion-dollar global industry and a core component of the broader $14.4 billion annual intravenous equipment market

The sheer volume of clinical use, with billions of catheters purchased globally each year, underscores the market's foundation in essential hospital care delivery. First-attempt insertion success rates remain a significant clinical challenge, driving demand for improved catheter designs, visualization technologies, and specialized insertion tools. Rising chronic disease prevalence, an aging global population, and expanding access to modern healthcare in developing nations all contribute to sustained demand.

• •Extensive clinical deployment and high insertion volumes create consistent demand dynamics across hospitals, clinics, and home-care settings
• •Insertion challenges, including multiple-attempt placements and catheter failures, fuel innovation in catheter design and ultrasound-guided insertion technologies
• •Post-pandemic healthcare infrastructure expansion and increased adoption of advanced IV therapies continue to accelerate market growth

The market encompasses a wide range of products, including standard PIVCs, safety-engineered catheters designed to reduce needlestick injuries, and specialized catheters for difficult venous access. Geographically, North America commands a substantial share driven by high hospital utilization rates and advanced clinical adoption, while the Asia-Pacific region is emerging as a key growth market due to improving healthcare access and rising medical device manufacturing capacity.

• •Product segmentation includes conventional catheters, safety-engineered devices, and ultrasound-compatible specialized catheters
• •North America represents a leading market, supported by high hospitalization rates and rapid adoption of advanced vascular access technologies
• •Emerging markets in Asia-Pacific, Latin America, and the Middle East are expanding rapidly due to healthcare infrastructure development and growing patient populations

What are the recent trends and outlook?

Innovation in the PIVC market is being shaped by clinical emphasis on first-attempt success, patient comfort, and healthcare worker safety, with ultrasound-guided insertion techniques gaining increasing adoption in difficult-access scenarios. Material science advances are driving the development of catheters that reduce phlebitis, infiltration, and dwell-time complications, while regulatory focus on healthcare-associated infections continues to influence product design and hospital procurement policies.

• •Ultrasound-guided peripheral IV insertion and specialized visualization tools are transforming clinical practice, particularly for patients with difficult venous access
• •Rising awareness of microplastic and particulate shedding from IV devices is prompting research into safer materials and filtration technologies
• •The market's long-term trajectory remains positive, with 5.45% annual growth expected through 2030 as aging populations and expanding healthcare access drive continued catheter demand